Startups
Edit
Braeburn Pharmaceuticals
https://www.braeburnpharmaceuticals.com/Last activity: 25.06.2024
Probably Closed
Long-acting therapies for opioid use disorders.
Princeton, NJ
Princeton, NJ
Overview
Total raised
$110M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 22, 2018 | FDA slaps down Braeburn on opioid addiction drug, putting Indivior and Alkermes in strong position | One of the frontrunners in the rush to get new opioid addiction treatments to the market has just hit a roadblock. Just days before its PDUFA date, Braeburn Pharmaceuticals got a complete response letter from the FDA in li... |
| Jan 12, 2018 | Term Sheet — Friday, January 12 | CUDDLE PUDDLES Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop Last night, Axios reported that one of these parties was held at venture capitalist Steve Jurvetson’s home. The party fol... |
| Jan 11, 2018 | RA Capital Joins $110M Funding for Braeburn Pharmaceuticals | Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Cap... |
| Jan 11, 2018 | Braeburn Pharmaceuticals Completes $110M Mezzanine Round of Financing | Braeburn Pharmaceuticals, Inc., a Princeton, N.J.-based pharmaceutical company, completed a $110m mezzanine round of financing. The round was led by Wellington Capital Management with participation from new investors Avista Capital Partners... |
| Jan 11, 2018 | Rock Springs Capital Joins $110M Funding for Braeburn Pharmaceuticals | Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating in the financing include Avista Cap... |
| Jan 11, 2018 | Braeburn Pharmaceuticals Nabs $110M | PRINCETON, N.J., Braeburn Pharmaceuticals, (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. >> Click here for more funding data on Braeburn ... |
| Jan 10, 2018 | Braeburn Announces Completion of $110 Million Financing | Princeton, N.J.— January 10, 2018 — Braeburn Pharmaceuticals, Inc. (Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management. Other new investors participating... |
| Jan 4, 2017 | Term Sheet — Wednesday, January 4 | DELL-EMC, NYC EXITS, HYPEMOBILES Hello from Las Vegas, where I’m riding in cars with robots and hunting down the most ridiculous “smart” items CES has to offer. (Current front-runners: a smart mattress and a smart hairbrush.) Paid Content S... |
Reviews 0
FAQ about Braeburn Pharmaceuticals
How much funding has Braeburn Pharmaceuticals raised?
Braeburn Pharmaceuticals has raised $110M in total across 1 funding round.
What has the press written about Braeburn Pharmaceuticals?
Parsers VC has collected 9 articles mentioning Braeburn Pharmaceuticals, among them “FDA slaps down Braeburn on opioid addiction drug, putting Indivior and Alkermes in strong position” (Jan 22, 2018) and “Term Sheet — Friday, January 12” (Jan 12, 2018).
Is Braeburn Pharmaceuticals still active?
Braeburn Pharmaceuticals is probably closed: its latest activity on Parsers VC dates from Jun 25, 2024.